Clustering data with hclust algorithm for (Study ST004188)

Reversed phase UNSPECIFIED ION MODE (Analysis AN006957)
MetaboliteStructureF1F2F3
T-alpha-MCAME11237930.171.032.02
Phytanic acidME11237941.001.000.99
Iso-DCAME11237990.731.410.96
FFA(18:0)-2-OHME11238371.070.950.95
CDCA-3SME11238100.272.340.67
FFA(20:2)ME11238280.971.080.96
TDCA-3SME11238190.201.431.61
alpha-MCAME11238130.491.531.14
FFA(20:3n3,6)ME11238271.001.001.01
FFA(20:4n6)ME11238260.951.100.97
FFA(18:2n6)ME11238340.881.180.98
12-oxoCDCAME11238180.831.310.93
DCA-3SME11238080.361.871.00
FFA(22:3n3)ME11238211.001.010.99
GCA-3SME11238060.151.771.36
7-oxoDCAME11238151.060.661.24
FFA(12:0-DC)ME11238380.981.410.64
FFA(19:1n9)ME11238301.010.991.00
3epi-DCAME11238170.851.300.90
FFA(22:1n9)ME11238251.011.030.96
DCAME11238090.711.450.95
T-beta-MCAME11237920.181.071.98
FFA(19:1)-isomerME11238311.000.991.01
GDCA-3SME11238030.241.021.95
GCDCA-3SME11238050.161.471.63
FFA(18:2n7)ME11238330.871.190.99
HDCAME11238000.871.320.87
FFA(18:4)ME11238320.951.080.99
NorCAME11237960.561.670.93
3-OxoDCAME11238160.721.720.68
TLCA-3SME11238140.301.641.29
GLCA-3SME11238020.541.221.37
FFA(22:4n6)ME11238430.991.040.98
GCAME11238070.171.781.33
FFA(22:3)-isomer_2ME11238230.971.011.03
UCAME11237970.592.200.41
FFA(18:1n7)ME11238360.741.420.94
FFA(22:3)-isomer_1ME11238220.921.150.95
LCA-3SME11237980.481.720.99
FFA(10:1n8)ME11238390.961.230.84
FFA(22:5n6)ME11238411.001.001.00
TCDCA-3SME11237910.152.190.96
omega-MCAME11237950.452.170.61
CAME11238120.561.630.97
FFA(22:6n3)ME11238400.961.100.96
CDCAME11238110.711.450.95
FFA(22:5n3)ME11238421.001.001.00
FFA(8:0)-3-OHME11238201.150.711.08
HCAME11238010.571.620.96
FFA(18:1n9)ME11238350.791.360.93
FFA(22:2)ME11238240.981.060.96
GDCAME11238040.211.701.35
FFA(20:0)-isomerME11238291.011.000.99

Factors:

F1Sample source:Urine | Factor:Health
F2Sample source:Urine | Factor:Liver-Gallbladder Damp-Heat
F3Sample source:Urine | Factor:Liver Qi Stagnation
Data matrix
  logo